🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mourad Tighiouart

Cedars-Sinai Medical Center

ORCID: 0000-0001-8021-5690

MathematicsEconomics, Econometrics and FinanceMedicinePharmacology, Toxicology and PharmaceuticsDecision Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.104Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data-driven discovery of medication effects on blood glucose from electronic health records

Patterns(2025)10.1016/j.patter.2025.101312

Top 78%

0.104DataRank

Top 78%1 citations

Caleb Cranney, So Yung Choi, Catherine Bresee, Mourad Tighiouart, Roma Gianchandani +4 more

Papers

Driven by 17 papers — median percentile 22. Top paper: “Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma”.

Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma

Scientific Reports(2022)10.1038/s41598-022-19401-3

N/A

0.587DataRank · unranked

10 citations

Shant Thomassian, Sungjin Kim, Gillian Gresham, Natalie Moshayedi, Jason Ye +9 more

Overall side effect assessment of oxaliplatin toxicity in rectal cancer patients in NRG oncology/NSABP R04

Quality of Life Research(2024)10.1007/s11136-024-03746-5

N/A

0.225DataRank · unranked

3 citations

Jessica Roydhouse, Mourad Tighiouart, N. Lynn Henry, Sungjin Kim, Ron D. Hays +4 more

Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial

JNCI Cancer Spectrum(2025)10.1093/jncics/pkaf032

N/A

0.208DataRank · unranked

3 citations

Sungjin Kim, N. Lynn Henry, Ron D. Hays, Vinícius F. Calsavara, Michael Luu +11 more

Data-driven discovery of medication effects on blood glucose from electronic health records

Patterns(2025)10.1016/j.patter.2025.101312

Top 78%

0.104DataRank

Top 78%1 citations

Caleb Cranney, So Yung Choi, Catherine Bresee, Mourad Tighiouart, Roma Gianchandani +4 more

Treatment of Cushing Disease With Pituitary-Targeting Seliciclib

The Journal of Clinical Endocrinology & Metabolism(2022)10.1210/clinem/dgac588

N/A

0DataRank · unranked

30 citations

Anat Ben-Shlomo, John D. Carmichael, Christina Wang, Ronald S. Swerdloff, Anthony P. Heaney +12 more

Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30

npj Breast Cancer(2022)10.1038/s41523-022-00489-9

N/A

0DataRank · unranked

9 citations

Sungjin Kim, Ron D. Hays, Márcio A. Diniz, Mourad Tighiouart, Gillian Gresham +6 more

Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma

Scientific Reports(2022)10.1038/s41598-022-23619-6

N/A

0DataRank · unranked

1 citations

Shant Thomassian, Sungjin Kim, Gillian Gresham, Natalie Moshayedi, Jason Ye +9 more

Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment

Cell Metabolism(2023)10.1016/j.cmet.2023.04.013

N/A

0DataRank · unranked

172 citations

So Yeon Kim, Wei Tu, Ji‐Eun Kim, Alexander M. Xu, Yoon Mee Yang +20 more

Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial

Cancer Prevention Research(2023)10.1158/1940-6207.capr-23-0216

N/A

0DataRank · unranked

4 citations

N. Lynn Henry, Ron D. Hays, Sungjin Kim, Michael Luu, Márcio A. Diniz +7 more

Dose Finding in Oncology Trials Guided by Ordinal Toxicity Grades Using Continuous Dose Levels

Entropy(2024)10.3390/e26080687

N/A

0DataRank · unranked

1 citations

André Rogatko, Mourad Tighiouart

DIET2TREAT: A randomized, multi-center, phase 2 trial of a ketogenic diet vs standard dietary guidance in combination with standard-of-care treatment for patients with newly diagnosed glioblastoma.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.tps2103

N/A

0DataRank · unranked

1 citations

Gillian Gresham, Nicholas Butowski, Katherine B. Peters, Akanksha Sharma, Ekokobe Fonkem +10 more

High-resolution Diffusion-weighted Imaging to Detect Changes in Tumor Size and ADC, and Predict Adverse Biopsy Histology during Prostate Cancer Active Surveillance

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0009

N/A

0DataRank · unranked

0 citations

Yibin Xie, Sungjin Kim, Yaniv Raphael, Christopher Nguyen, Daniel Luthringer +6 more

Evaluating Treatment Tolerability in Cancer Clinical Trials Using the Toxicity Index

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa028

N/A

0DataRank · unranked

40 citations

Márcio A. Diniz, Zahra S. Razaee, Michael Luu, Sungjin Kim, Ron D. Hays +6 more

Analyses of adverse events and patient‐reported outcomes with the toxicity index in cancer clinical trials

Cancer(2025)10.1002/cncr.70086

N/A

0DataRank · unranked

1 citations

N. Lynn Henry, Hanna Bandos, Vinícius F. Calsavara, Reena S. Cecchini, Márcio A. Diniz +8 more

A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations with Ordinal Toxicity Grades

Stats(2020)10.3390/stats3030017

N/A

0DataRank · unranked

7 citations

Sungjin Kim, Mourad Tighiouart, Márcio A. Diniz

Home-based virtual reality for chronic pain: protocol for an NIH-supported randomised-controlled trial

BMJ Open(2021)10.1136/bmjopen-2021-050545

N/A

0DataRank · unranked

41 citations

Sam Eberlein, Genie Alvarez, Rebecca Gale, Taylor Dupuy, Katherine Makaroff +15 more

Visualizing adverse events in clinical trials using correspondence analysis with R-package visae

BMC Medical Research Methodology(2021)10.1186/s12874-021-01368-w

N/A

0DataRank · unranked

0 citations

Gillian Gresham, Sungjin Kim, Michael Luu, N. Lynn Henry, Mourad Tighiouart +4 more